Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Alopexx, Inc., a clinical stage biotechnology company, focusing on developing novel immune therapeutics for the prevention, treatment, and mitigation of bacterial, fungal, and parasitic infections. Its lead products include Vaccine AV0328, a synthetic poly N-acetyl glucosamine (PNAG) vaccine that has completed Phase I first-in-man trial for the treatment of streptococcus pneumoniae, meningococcal infections, Alzheimer's disease, and type 1 diabet… Read full Trend Edge analysis →
| Current Price | $9.95 |
|---|---|
| Market Cap | N/A |
| Float | 1.9M |
| Dividend Rate | None |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | -$1.7M | N/A | N/A |
| 2021 | N/A | -$956,954 | N/A | N/A |
| Quarter | Revenue | Net Income |
|---|---|---|
| Sep 2021 | N/A | N/A |
| Dec 2021 | N/A | N/A |
| Mar 2022 | N/A | -$500,222 |
| Jun 2022 | N/A | -$539,763 |
| Insider Ownership | 44.7% |
|---|---|
| Short Float | 0.0% |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $0.00 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $0.00 | Medium-term trend |
| Weekly | 80-Week SMA | $0.00 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $0.00 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $0.00 | Near-term monthly trend |
| Monthly | 20-Month SMA | $0.00 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $0.00 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Volume shelf data not available.
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | N/A | N/A | N/A | N/A | N/A |
| 1 Day | N/A | N/A | N/A | N/A | N/A |
| 1 Week | N/A | N/A | N/A | N/A | N/A |
| 2 Weeks | N/A | N/A | N/A | N/A | N/A |
| 1 Month | N/A | N/A | N/A | N/A | N/A |
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
Institutional holder breakdown coming soon.
Total insider ownership: 44.7%
Founder-led management: Daniel R Vlock (Co-Founder, Chief Executive Officer and Chairman of the Board Designee), Gerald B. Pier (Co-Founder, Chief Scientific Advisor, Chair Scientific Advisory Board)
| Total Filings | 1 |
|---|---|
| Net Value | +N/A |
| Net Shares Change | 187,500 |
| % of Float | 9.9% |
| C-Suite Filings | 0 |
| Clusters Detected | 0 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| Hugreat Ltd | +N/A | 1 | 1 buy |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-07-02 | Hugreat Ltd | +N/A | N/A |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Alopexx, Inc. (ALPX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for ALPX on Trend Edge →